Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $528,114 - $661,784
-9,118 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$64.88 - $73.64 $64,815 - $73,566
999 Added 12.3%
9,118 $662,000
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $78,452 - $84,641
1,159 Added 16.65%
8,119 $567,000
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $441,751 - $482,675
6,960 New
6,960 $479,000
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $40,834 - $45,790
-660 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $41,269 - $46,233
660 New
660 $42,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Little House Capital LLC Portfolio

Follow Little House Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Little House Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Little House Capital LLC with notifications on news.